| 1 |
35242827 | BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors. | 2022 |
4 |
| 2 |
33536037 | Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin. | 2021 Feb 3 |
1 |
| 3 |
33896588 | Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature. | 2021 Jul |
1 |
| 4 |
32331767 | Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency. | 2020 Jun |
1 |
| 5 |
32876438 | Potential Doxorubicin-Mediated Dual-Targeting Chemotherapy in FANC/BRCA-Deficient Tumors via Modulation of Cellular Formaldehyde Concentration. | 2020 Oct 19 |
2 |
| 6 |
33074587 | EBV-encoded miRNAs can sensitize nasopharyngeal carcinoma to chemotherapeutic drugs by targeting BRCA1. | 2020 Nov |
1 |
| 7 |
31215481 | MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer. | 2019 Jun 18 |
3 |
| 8 |
31411802 | BRCA mutation frequency and clinical features of ovarian cancer patients: A report from a Chinese study group. | 2019 Nov |
1 |
| 9 |
31511498 | Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response. | 2019 Sep 11 |
1 |
| 10 |
29298688 | Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations. | 2018 Jan 3 |
1 |
| 11 |
29686231 | Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1. | 2018 Apr 23 |
1 |
| 12 |
29784019 | The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma. | 2018 May 21 |
1 |
| 13 |
29929045 | Regulation of DNA repair in the absence of classical non-homologous end joining. | 2018 Aug |
1 |
| 14 |
30028120 | Overcoming Chemoresistance in Cancer via Combined MicroRNA Therapeutics with Anticancer Drugs Using Multifunctional Magnetic Core-Shell Nanoparticles. | 2018 Aug 15 |
1 |
| 15 |
28881292 | Exceptionally high UBE2C expression is a unique phenomenon in basal-like type breast cancer and is regulated by BRCA1. | 2017 Nov |
2 |
| 16 |
26785283 | Ovarian cancer treatment in mutation carriers/BRCAness. | 2016 Oct |
1 |
| 17 |
27113739 | Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers. | 2016 May |
1 |
| 18 |
27555886 | Cytotoxic and targeted therapy for hereditary cancers. | 2016 |
2 |
| 19 |
24996439 | The Fanconi anemia/BRCA pathway is involved in DNA interstrand cross-link repair of adriamycin-resistant leukemia cells. | 2015 Mar |
2 |
| 20 |
25993149 | Chemotherapy for Patients with BRCA1 and BRCA2-Mutated Ovarian Cancer: Same or Different? | 2015 |
1 |
| 21 |
26027929 | MERIT40 Is an Akt Substrate that Promotes Resolution of DNA Damage Induced by Chemotherapy. | 2015 Jun 9 |
2 |
| 22 |
25337234 | Effect of adriamycin on BRCA1 and PARP-1 expression in MCF-7 breast cancer cells. | 2014 |
7 |
| 23 |
23376355 | 3,3'-Diindolymethane ameliorates adriamycin-induced cardiac fibrosis via activation of a BRCA1-dependent anti-oxidant pathway. | 2013 Apr |
1 |
| 24 |
23548133 | Systemic treatment for hereditary cancers: a 2012 update. | 2013 Apr 1 |
1 |
| 25 |
23670255 | BRCA1 and p53 regulate critical prostate cancer pathways. | 2013 Sep |
2 |
| 26 |
22807977 | BRCA1 protein levels and PIK3CA mutations as predictive biomarkers for response to neoadjuvant chemotherapy in locally advanced breast cancer: An exploratory analysis. | 2012 Jul |
1 |
| 27 |
22832221 | Dynamic coregulatory complex containing BRCA1, E2F1 and CtIP controls ATM transcription. | 2012 |
2 |
| 28 |
21700680 | BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer. | 2011 Aug |
3 |
| 29 |
21835933 | BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin. | 2011 Oct |
1 |
| 30 |
21864706 | BRCA1 is required for hMLH1 stabilization following doxorubicin-induced DNA damage. | 2011 Dec |
6 |
| 31 |
21945552 | A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer. | 2011 Dec |
1 |
| 32 |
19593673 | Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells. | 2009 |
1 |
| 33 |
19820363 | Family history of cancer rather than p53 status predicts efficacy of pegylated liposomal doxorubicin and oxaliplatin in relapsed ovarian cancer. | 2009 Aug |
1 |
| 34 |
17492376 | Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers. | 2008 Mar |
1 |
| 35 |
15607317 | Development and applications of a real-time quantitative RT-PCR method (QRT-PCR) for BRCA1 mRNA. | 2005 Jan |
1 |
| 36 |
12684687 | The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells. | 2003 May |
1 |
| 37 |
12698198 | BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. | 2003 Apr 22 |
1 |
| 38 |
12024039 | BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets. | 2002 Jun |
1 |
| 39 |
12170778 | BRCA1 transcriptionally regulates damaged DNA binding protein (DDB2) in the DNA repair response following UV-irradiation. | 2002 Mar-Apr |
1 |
| 40 |
11295099 | Regulation of BRCA1 and BRCA2 transcript in response to cisplatin, adriamycin, taxol and ionising radiation is correlated to p53 functional status in ovarian cancer cell lines. | 2001 May-Jun |
1 |
| 41 |
10764811 | Nuclear localization and cell cycle-specific expression of CtIP, a protein that associates with the BRCA1 tumor suppressor. | 2000 Jun 16 |
1 |
| 42 |
10884389 | Repression of BRCA1 through a feedback loop involving p53. | 2000 Oct 13 |
3 |
| 43 |
10196224 | Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage. | 1999 Apr 16 |
2 |
| 44 |
10344722 | Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells. | 1999 Jun 15 |
1 |
| 45 |
9619832 | Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. | 1998 Apr 30 |
7 |
| 46 |
9679765 | Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation. | 1998 Aug 12 |
2 |